Frontiers | From targeted therapy to a novel way: Immunogenic cell death in lung cancer,Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway | Cell & Bioscience | Full Text,Recent Advances in Nanoimmunotherapy by Modulating Tumor-Associated Macrophages for Cancer Therapy | Bioconjugate Chemistry,A mitochondria-targeting dihydroartemisinin derivative as a reactive oxygen species -based immunogenic cell death inducer - ScienceDirect,Digestive cancers: mechanisms, therapeutics and management | Signal Transduction and Targeted Therapy